pharma · Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Bayer | Pharmaceuticals
Bayer Australia Ltd
Bayer Australia is a pharma organization headquartered in Pymble, AU. Primary therapeutic focus areas include Transthyretin Amyloid Cardiomyopathy (ATTR-CM). NovaPharmaNews links 2 clinical program(s), 10 drug profile(s)
Berlin, DE HQ
4 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Berlin, DE
- Employees
- 4
- Programs
- 2
- Drugs
- 15
- Patents
- 1
BEYONTTRA 356 mg film-coated tablets
Approved · small molecule · Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
BEYONTTRA 356 mg film-coated tablets for Transthyretin Amyloid Cardiomyopathy (ATTR-CM) is a Approved program (small_molecule) at Bayer Australia Ltd with 1 ClinicalTrials.gov record(s).
Internal code 23026
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Bayer Australia Ltd
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
- Status
- active
- Trials
- 1